Search

everythinglearnresearchcommunity

for

Search:↓

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Adalimumab may cause severe hair loss in some patients.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

Alopecia areata involves unique activation of certain immune cells.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

A rare genetic mutation caused severe symptoms in a 6-year-old girl with mandibuloacral dysplasia type A.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

Eosinophils are not a reliable marker for diagnosing alopecia areata.

Satoyoshi Syndrome is hard to diagnose and treat due to its rarity and complex symptoms.

Blocking LFA-1 prevents hair loss in mice.

Infliximab may cause hair loss in Crohn's disease patients.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Systemic lupus erythematosus is an autoimmune disease causing diverse symptoms and major organ involvement.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

MCTD should be considered in children with recurring muscle issues, lupus-like symptoms, and edema.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Alopecia Areata might be linked to Crohn's disease.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

The patient had paraneoplastic pemphigus without mucosal involvement.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.